The development of biotech drugs typically involves several stages. It starts with the identification of a biological target, such as a protein or gene associated with a disease. Researchers then use technologies like genomics and proteomics to understand the target and identify potential drug candidates. These candidates undergo rigorous preclinical testing in the lab and in animal models. Successful candidates move on to clinical trials, where they are tested in humans for safety and efficacy.
